In a hearing on January 13, 2026, Novo Nordisks attorney Katie Insogna gave a breakdown of injuries listed in lawsuits in the MDL
Because of this, the manufacturer did not take the concept further. When SGLT-2 inhibitors like Invokana, Farxiga, and Jardiance emerged in 2013 and 2014, researchers began testing these medications in type 1 diabetes in a series of trials
Epilepsy and brain network hubs
Tissue repair effects appear to take a few weeks, with individual responses varying
Bermudez Brito M, Goulielmaki E, Papakonstanti EA
Some experimental results suggest significant increases in circulating IGF-1, which is thought to act as a downstream mediator of growth hormone activity